{
    "organizations": [],
    "uuid": "411e78c3b30511187aeadae491af88f2cdfee2df",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-juniper-pharmaceuticals-to-explore/brief-juniper-pharmaceuticals-to-explore-strategic-alternatives-idUSASB0C39S",
    "ord_in_thread": 0,
    "title": "BRIEF-Juniper Pharmaceuticals To Explore Strategic Alternatives",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 31, 2018 / 2:29 PM / in 11 minutes BRIEF-Juniper Pharmaceuticals To Explore Strategic Alternatives Reuters Staff \nJan 31 (Reuters) - Juniper Pharmaceuticals Inc: \n* JUNIPER PHARMACEUTICALS TO EXPLORE STRATEGIC ALTERNATIVES \n* JUNIPER PHARMACEUTICALS - ‍ ENGAGED ROTHSCHILD AS ITS INDEPENDENT FINANCIAL ADVISOR TO ASSIST JUNIPER IN EVALUATING POTENTIAL STRATEGIC ALTERNATIVES​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-31T22:29:00.000+02:00",
    "crawled": "2018-01-31T16:41:44.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "pharmaceutical",
        "explore",
        "strategic",
        "alternative",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "juniper",
        "pharmaceutical",
        "inc",
        "juniper",
        "pharmaceutical",
        "explore",
        "strategic",
        "alternative",
        "juniper",
        "pharmaceutical",
        "engaged",
        "rothschild",
        "independent",
        "financial",
        "advisor",
        "assist",
        "juniper",
        "evaluating",
        "potential",
        "strategic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}